Systemic physiological "noise" in fMRI has clinical relevance

Area of Science:

• Neuroimaging
• Neuropharmacology
• Addiction Science

Background:

• Functional magnetic resonance imaging (fMRI) is crucial for neuroscience but lacks clinical application.
• The systemic low-frequency oscillation (sLFO) is an fMRI signal component often disregarded as noise.
• sLFOs are associated with blood flow and physiological arousal.

Purpose of the Study:

• To investigate the potential of sLFOs as a biomarker for drug use phenotypes.
• To explore the relationship between sLFO amplitude and nicotine dependence, craving, and response to methylphenidate.

Main Methods:

• Analysis of fMRI data focusing on sLFO amplitude in individuals with chronic nicotine use and healthy controls.
• Correlational analysis linking sLFO amplitude to dependence severity and cue-induced craving.
• Assessment of sLFO response to acute methylphenidate and nicotine administration in healthy participants.

Main Results:

• In chronic nicotine users, sLFO amplitude increased during abstinence and correlated with dependence and craving.
• In healthy individuals, methylphenidate, but not nicotine, reduced sLFO amplitude, correlating with improved performance.
• sLFOs demonstrate sensitivity to drug administration, cues, and abstinence states.

Conclusions:

• The sLFO component of the fMRI signal contains significant biological information relevant to drug use.
• sLFOs can serve as a complementary biomarker to traditional fMRI analyses, potentially increasing clinical utility.
• Accounting for sLFOs is essential for accurate interpretation of fMRI data across various experimental conditions.